At Week 1 , mean dizziness/lightheadedness score change favored droxidopa by 1.5 units ( p = 0.24 ) , with subsequent numerical differences favoring droxidopa throughout the observation period , and at Week 1 , mean standing systolic blood-pressure change favored droxidopa by 12.5 mmHg ( p = 0.04 ) .